Radiopharmaceutical Market is Estimated to Attain a Value of US$7,430.8 Million by 2024

1. ©2019 Transparency Market Research, All Rights Reserved Radiopharmaceutical Market Radioisotope - Technetium-99, Gallium-67, Iodine-123, 18F, Rubidium-82, Yttrium-90, and Lutetium-177; End User - Hospitals, Ambulatory Surgical Centers, and Diagnostic Centers; and Source - Nuclear Reactor and Cyclotrons Forecast 2017 - 2024 ©2019 Transparency Market Research, All Rights Reserved

2. ©2019 Transparency Market Research, All Rights Reserved Table of Content Sr. No. Content Chapter1 Preface Chapter 2 Assumptions and Research Methodology Chapter 3 Executive Summary: Global Radiopharmaceutical Market Chapter 4 Market Overview Chapter 5 Global Radiopharmaceutical Market Analysis and Forecasts, By Radioisotopes Chapter 6 Global Radiopharmaceutical Market Analysis and Forecasts, By Source Chapter 7 Global Radiopharmaceutical Market Analysis and Forecasts, By End-user Chapter 8 Global Radiopharmaceutical Market Analysis and Forecasts, By End-user Chapter 9 Global Radiopharmaceutical Market Analysis and Forecasts, By Region Chapter 10 North America Radiopharmaceutical Market Analysis and Forecast Chapter 11 Europe Radiopharmaceutical Market Analysis and Forecast Chapter 12 Asia Pacific Radiopharmaceutical Market Analysis and Forecast Chapter 13 Latin America Radiopharmaceutical Market Analysis and Forecast Chapter 14 Middle East and Africa Radiopharmaceutical Market Analysis and Forecast Chapter 15 Competition Landscape

3. ©2019 Transparency Market Research, All Rights Reserved Radiopharmaceutical Market: Snapshot Increase in incidence of various diseases, development of new sources for radioisotope production, and rise in demand for nuclear medicine are boosting the radiopharmaceutical market. • Radiopharmaceutical market has been segmented into two major categories: nuclear reactors and cyclotrons. • The strong prevalence of cancer and cardiovascular diseases, growing awareness regarding its positive effects, increasing preference of SPECT and PET scans, and advancements in radiotracers are some of the key drivers of the radiopharmaceuticals market. • ©2019 Transparency Market Research, All Rights Reserved

4. ©2019 Transparency Market Research, All Rights Reserved ©2019 Transparency Market Research, All Rights Reserved

5. ©2019 Transparency Market Research, All Rights Reserved Reports Highlights • global radiopharmaceuticals market will increment at a steady CAGR of 5.4% during the forecast period of 2017 to 2024. Revenue-wise, the global radiopharmaceuticals market is estimated to attain a value of US$7,430.8 million by 2024, mounting from its calculated worth of US$5,145.1 million as of 2017. • Major players profiled in this report include Advanced Accelerator Applications (AAA), Eckert & Ziegler, GE Healthcare, IBA Radiopharma Solutions, Lantheus Holdings, Inc., Mallinckrodt PLC, Nordion, Inc., Siemens Healthineers, and Positron Corporation. ©2019 Transparency Market Research, All Rights Reserved Request Sample

6. ©2019 Transparency Market Research, All Rights Reserved To know more about us, please visit our website: www.transparencymarketresearch.com For sales queries or new topics email us on: sales@transparencymarketresearch.com For other queries contact: 90 State Street, Albany NY – 12207, United States Tel: +1-518-618-1030 T H A N K Y O U